or Try an Advanced Search...

    Technical Analysis for OMGA - Omega Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.79 3.97% 0.03
    OMGA closed up 3.97 percent on Wednesday, November 20, 2024, on 70 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical OMGA trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 3.97%
    NR7 Range Contraction 3.97%
    Narrow Range Bar Range Contraction 3.97%
    Lower Bollinger Band Walk Weakness 3.97%
    Wide Bands Range Expansion 3.97%
    Below Lower BB Weakness 3.97%
    Older End-of-Day Signals for OMGA ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 20 hours ago
    Rose Above Previous Day's High about 20 hours ago
    Up 5% about 20 hours ago
    Up 3% about 21 hours ago
    1.5x Volume Pace about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    OMGA Chart by TradingView
    Basic chart:

    Profile

    Omega Therapeutics, Inc., a biotechnology company, develops genomic medicines to cure diseases. The company focuses on precision tuning to activate the human genome's native capacity to treat and cure diseases. It engages in designing, engineering, and manufacturing Epigenomic Controllers to target the GenomStats for the cell types of interest, with the ability to downregulate or upregulate genomic activity for therapeutic effect. Omega Therapeutics, Inc. was formerly known as VL42, Inc. and changed its name to Omega Therapeutics, Inc. in July 2017. The company was incorporated in 2016 and is based in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Disease Human Genome

    Is OMGA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 17 Omega Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
    Nov 15 Omega Therapeutics reports Q3 results
    Nov 14 Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates
    Nov 14 Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results
    Oct 29 Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last?
    Oct 23 Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
    Oct 15 Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
    Oct 3 Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
    Sep 17 Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
    Aug 14 Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
    See more OMGA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.3
    52 Week Low 0.75
    Average Volume 316,316
    200-Day Moving Average 2.14
    50-Day Moving Average 1.15
    20-Day Moving Average 1.09
    10-Day Moving Average 0.97
    Average True Range 0.12
    RSI (14) 32.89
    ADX 22.62
    +DI 18.22
    -DI 25.82
    Chandelier Exit (Long, 3 ATRs) 1.33
    Chandelier Exit (Short, 3 ATRs) 1.11
    Upper Bollinger Bands 1.47
    Lower Bollinger Band 0.72
    Percent B (%b) 0.09
    BandWidth 68.58
    MACD Line -0.10
    MACD Signal Line -0.06
    MACD Histogram -0.0399
    Fundamentals Value
    Market Cap 43.57 Million
    Num Shares 55.1 Million
    EPS -2.08
    Price-to-Earnings (P/E) Ratio -0.38
    Price-to-Sales 74.95
    Price-to-Book 2.61
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.86
    Resistance 3 (R3) 0.86 0.83 0.85
    Resistance 2 (R2) 0.83 0.81 0.83 0.84
    Resistance 1 (R1) 0.81 0.80 0.82 0.81 0.84
    Pivot Point 0.79 0.79 0.79 0.79 0.79
    Support 1 (S1) 0.77 0.77 0.78 0.77 0.74
    Support 2 (S2) 0.74 0.76 0.74 0.74
    Support 3 (S3) 0.72 0.74 0.73
    Support 4 (S4) 0.72